Cybozu, Inc.
Notice Regarding the Occurrence of Extraordinary Loss (Non-Consolidated Financial Results)
Recorded an extraordinary loss of 1,485 million yen for impairment on equity-method investments in the 2025 December non-consolidated financial results. No impact on consolidated financial results.
Key Figures
- Extraordinary Loss Amount: 1,485 million yen (Impairment loss on equity-method investments)
- Target Company: Kintone Corporation (consolidated subsidiary)
- Impact on Consolidated Financial Results: None
AI要約
Overview of the Extraordinary Loss
Cybozu, Inc. recorded an impairment loss of 1,485 million yen on the shares of Kintone Corporation, a consolidated subsidiary, as an extraordinary loss in its non-consolidated financial results for the fiscal year ending December 2025. Although losses temporarily accumulated due to the investment phase of the U.S. business, the company expects long-term growth potential and plans to continue investments.
Impact on Earnings and Consolidated Financial Results
This extraordinary loss is already reflected in the previously disclosed full-year non-consolidated earnings projection for the fiscal year ending December 2025 and is eliminated in consolidation, thus having no impact. Investors should note that there will be no changes to consolidated earnings.
